Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion type Assertion NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_head.
- NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion description "[This Clinical Practice Guideline will therefore, focus on HFE-HC, while rarer forms of genetic iron overload recently attributed to pathogenic mutations of transferrin receptor 2, (TFR2), hepcidin (HAMP), hemojuvelin (HJV), or to a sub-type of ferroportin (FPN) mutations, on which limited and sparse clinical and epidemiologic data are available, will not be discussed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_provenance.
- NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion evidence source_evidence_literature NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_provenance.
- NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion SIO_000772 20471131 NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_provenance.
- NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion wasDerivedFrom befree-20140225 NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_provenance.
- NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_assertion wasGeneratedBy ECO_0000203 NP239168.RAcwEwLxlmR72fxGYd_Bq2DDZtTifZUP3vGkMAwCHggs0130_provenance.